arXiv:2608.24723v1 Announce Type: new Abstract: Retinal fundus photography is widely used for screening and monitoring ocular diseases, but many modern classification pipelines rely on deep latent re...
arXiv:2602.08580v4 Announce Type: replace-cross Abstract: Automatic extraction of retinal vascular biomarkers from color fundus images (CFI) is crucial for large-scale studies of the retinal vasculat...
arXiv:2606. 16234v1 Announce Type: cross Abstract: Fundus fluorescein angiography (FFA) is critical for assessing retinal vascular abnormalities, but its acquisition is invasive and not always feasible.
arXiv:2510.07277v2 Announce Type: replace Abstract: Diabetic Macular Edema (DME) is a leading cause of vision loss among patients with Diabetic Retinopathy (DR). While deep learning has shown promisi...
arXiv:2607. 21068v1 Announce Type: new Abstract: Automated detection of vision impairing retina-based ocular conditions from fundus images is important for early screening, timely referral and reducing dependency on specialist-only assessment, for which neural network-based deep learning (DL) models have been widely utilized.
arXiv:2607. 03959v1 Announce Type: cross Abstract: Diabetic retinopathy (DR) is a leading cause of vision impairment worldwide, highlighting the need for accurate and accessible screening tools.
The paper presents an explainable diabetic retinopathy classification framework that leverages vision foundation models—DINOv2, CLIP, and Vision Transformer—combined with various transfer learning techniques such as full fine‑tuning, linear probing, and Low‑Rank Adaptation (LoRA). Using the ODIR dataset for internal validation and the APTOS dataset for external testing, DINOv2‑LoRA achieved the best internal AUROC (0.758) while DINOv2 and ViT full fine‑tuning reached the highest external AUROC (0.920). Explainability was assessed with Grad‑CAM and HiResCAM against expert‑annotated lesion masks from IDRiD, using Dice, IoU, and Pointing Game metrics, confirming that model attention aligns with clinically relevant retinal lesions.
arXiv:2603. 18846v3 Announce Type: replace-cross Abstract: Foundation models are used to extract transferable representations from large amounts of unlabeled data, typically via self-supervised learning (SSL).
The paper explores contrastive self‑supervised learning (SSL) for retinal fundus image classification, comparing SimSiam and SimCLR under limited data and computational resources. It investigates how retinal‑specific augmentation strategies and training parameters affect representation quality, evaluated through linear probing and fine‑tuning on multi‑disease classification and diabetic retinopathy grading tasks. The results demonstrate that tailored augmentations enable lightweight SSL models to learn transferable representations, reducing reliance on large annotated datasets while achieving competitive performance.
The paper explores contrastive self‑supervised learning (SSL) for retinal fundus image classification, comparing SimSiam and SimCLR under limited data and computational resources. It investigates how retinal‑specific augmentation strategies and training parameters affect representation quality, evaluated through linear probing and fine‑tuning on multi‑disease classification and diabetic retinopathy grading tasks. Results indicate that tailored augmentations enable lightweight SSL models to learn transferable representations, reducing reliance on large annotated datasets while achieving competitive performance.
Automated diabetic retinopathy (DR) grading from colour fundus photographs can achieve strong predictive performance, but clinical interpretation requires more than an image-level label. It requires understanding how lesion evidence is distributed around retinal vessels and how this evidence relates to quantitative vascular biomarkers.
arXiv:2608. 09752v1 Announce Type: cross Abstract: Retinal fundus images frequently exhibit multiple co-occurring pathologies, yet standard deep learning classifiers apply static, identical computation to every image regardless of the underlying disease distribution.